 | • レポートコード：MRC2-11QY12652 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は髄膜炎菌コンジュゲートのグローバル市場について調査・分析したレポートです。種類別（メナクトラ、メンベオ、ネイスバックC、ニメンリックス、その他）市場規模、用途別（子供、10代前/10代、成人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別髄膜炎菌コンジュゲートの競争状況、市場シェア ・世界の髄膜炎菌コンジュゲート市場：種類別市場規模 2015年-2020年（メナクトラ、メンベオ、ネイスバックC、ニメンリックス、その他） ・世界の髄膜炎菌コンジュゲート市場：種類別市場規模予測 2021年-2026年（メナクトラ、メンベオ、ネイスバックC、ニメンリックス、その他） ・世界の髄膜炎菌コンジュゲート市場：用途別市場規模 2015年-2020年（子供、10代前/10代、成人） ・世界の髄膜炎菌コンジュゲート市場：用途別市場規模予測 2021年-2026年（子供、10代前/10代、成人） ・北米の髄膜炎菌コンジュゲート市場分析：米国、カナダ ・ヨーロッパの髄膜炎菌コンジュゲート市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの髄膜炎菌コンジュゲート市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の髄膜炎菌コンジュゲート市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの髄膜炎菌コンジュゲート市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi Pasteur、Pfizer、Glaxo Smith Kline、Hualan Biological Engineering、JN International Medical Corporation、Baxter International、Merck、Serum Institute of India、Biomed、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It’s a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.
Market Analysis and Insights: Global Meningococcal Conjugate Market
The global Meningococcal Conjugate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Meningococcal Conjugate Scope and Market Size
Meningococcal Conjugate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi Pasteur
Pfizer
Glaxo Smith Kline
Hualan Biological Engineering
JN International Medical Corporation
Baxter International
Merck
Serum Institute of India
Biomed
Novartis
Market segment by Type, the product can be split into
Menactra
Menveo
NeisVac-C
Nimenrix
Others
Market segment by Application, split into
Children
Preteens or Teens
Adults
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Meningococcal Conjugate Revenue
1.4 Market by Type
1.4.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Menactra
1.4.3 Menveo
1.4.4 NeisVac-C
1.4.5 Nimenrix
1.4.6 Others
1.5 Market by Application
1.5.1 Global Meningococcal Conjugate Market Share by Application: 2020 VS 2026
1.5.2 Children
1.5.3 Preteens or Teens
1.5.4 Adults
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Conjugate Market Perspective (2015-2026)
2.2 Global Meningococcal Conjugate Growth Trends by Regions
2.2.1 Meningococcal Conjugate Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Meningococcal Conjugate Historic Market Share by Regions (2015-2020)
2.2.3 Meningococcal Conjugate Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Meningococcal Conjugate Market Growth Strategy
2.3.6 Primary Interviews with Key Meningococcal Conjugate Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Conjugate Players by Market Size
3.1.1 Global Top Meningococcal Conjugate Players by Revenue (2015-2020)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2015-2020)
3.1.3 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Meningococcal Conjugate Market Concentration Ratio
3.2.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2019
3.3 Meningococcal Conjugate Key Players Head office and Area Served
3.4 Key Players Meningococcal Conjugate Product Solution and Service
3.5 Date of Enter into Meningococcal Conjugate Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Meningococcal Conjugate Historic Market Size by Type (2015-2020)
4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Meningococcal Conjugate Market Size by Application (2015-2020)
5.2 Global Meningococcal Conjugate Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Meningococcal Conjugate Market Size (2015-2020)
6.2 Meningococcal Conjugate Key Players in North America (2019-2020)
6.3 North America Meningococcal Conjugate Market Size by Type (2015-2020)
6.4 North America Meningococcal Conjugate Market Size by Application (2015-2020)
7 Europe
7.1 Europe Meningococcal Conjugate Market Size (2015-2020)
7.2 Meningococcal Conjugate Key Players in Europe (2019-2020)
7.3 Europe Meningococcal Conjugate Market Size by Type (2015-2020)
7.4 Europe Meningococcal Conjugate Market Size by Application (2015-2020)
8 China
8.1 China Meningococcal Conjugate Market Size (2015-2020)
8.2 Meningococcal Conjugate Key Players in China (2019-2020)
8.3 China Meningococcal Conjugate Market Size by Type (2015-2020)
8.4 China Meningococcal Conjugate Market Size by Application (2015-2020)
9 Japan
9.1 Japan Meningococcal Conjugate Market Size (2015-2020)
9.2 Meningococcal Conjugate Key Players in Japan (2019-2020)
9.3 Japan Meningococcal Conjugate Market Size by Type (2015-2020)
9.4 Japan Meningococcal Conjugate Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Meningococcal Conjugate Market Size (2015-2020)
10.2 Meningococcal Conjugate Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Meningococcal Conjugate Market Size by Type (2015-2020)
10.4 Southeast Asia Meningococcal Conjugate Market Size by Application (2015-2020)
11 India
11.1 India Meningococcal Conjugate Market Size (2015-2020)
11.2 Meningococcal Conjugate Key Players in India (2019-2020)
11.3 India Meningococcal Conjugate Market Size by Type (2015-2020)
11.4 India Meningococcal Conjugate Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Meningococcal Conjugate Market Size (2015-2020)
12.2 Meningococcal Conjugate Key Players in Central & South America (2019-2020)
12.3 Central & South America Meningococcal Conjugate Market Size by Type (2015-2020)
12.4 Central & South America Meningococcal Conjugate Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Details
13.1.2 Sanofi Pasteur Business Overview
13.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
13.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2015-2020))
13.1.5 Sanofi Pasteur Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Meningococcal Conjugate Introduction
13.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Glaxo Smith Kline
13.3.1 Glaxo Smith Kline Company Details
13.3.2 Glaxo Smith Kline Business Overview
13.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
13.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2015-2020)
13.3.5 Glaxo Smith Kline Recent Development
13.4 Hualan Biological Engineering
13.4.1 Hualan Biological Engineering Company Details
13.4.2 Hualan Biological Engineering Business Overview
13.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
13.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2015-2020)
13.4.5 Hualan Biological Engineering Recent Development
13.5 JN International Medical Corporation
13.5.1 JN International Medical Corporation Company Details
13.5.2 JN International Medical Corporation Business Overview
13.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
13.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2015-2020)
13.5.5 JN International Medical Corporation Recent Development
13.6 Baxter International
13.6.1 Baxter International Company Details
13.6.2 Baxter International Business Overview
13.6.3 Baxter International Meningococcal Conjugate Introduction
13.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2015-2020)
13.6.5 Baxter International Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Meningococcal Conjugate Introduction
13.7.4 Merck Revenue in Meningococcal Conjugate Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Serum Institute of India
13.8.1 Serum Institute of India Company Details
13.8.2 Serum Institute of India Business Overview
13.8.3 Serum Institute of India Meningococcal Conjugate Introduction
13.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2015-2020)
13.8.5 Serum Institute of India Recent Development
13.9 Biomed
13.9.1 Biomed Company Details
13.9.2 Biomed Business Overview
13.9.3 Biomed Meningococcal Conjugate Introduction
13.9.4 Biomed Revenue in Meningococcal Conjugate Business (2015-2020)
13.9.5 Biomed Recent Development
13.10 Novartis
13.10.1 Novartis Company Details
13.10.2 Novartis Business Overview
13.10.3 Novartis Meningococcal Conjugate Introduction
13.10.4 Novartis Revenue in Meningococcal Conjugate Business (2015-2020)
13.10.5 Novartis Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Meningococcal Conjugate Key Market Segments
Table 2. Key Players Covered: Ranking by Meningococcal Conjugate Revenue
Table 3. Ranking of Global Top Meningococcal Conjugate Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Menactra
Table 6. Key Players of Menveo
Table 7. Key Players of NeisVac-C
Table 8. Key Players of Nimenrix
Table 9. Key Players of Others
Table 10. Global Meningococcal Conjugate Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Meningococcal Conjugate Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Meningococcal Conjugate Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Meningococcal Conjugate Market Share by Regions (2015-2020)
Table 14. Global Meningococcal Conjugate Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Meningococcal Conjugate Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Meningococcal Conjugate Market Growth Strategy
Table 20. Main Points Interviewed from Key Meningococcal Conjugate Players
Table 21. Global Meningococcal Conjugate Revenue by Players (2015-2020) (Million US$)
Table 22. Global Meningococcal Conjugate Market Share by Players (2015-2020)
Table 23. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Conjugate as of 2019)
Table 24. Global Meningococcal Conjugate by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Meningococcal Conjugate Product Solution and Service
Table 27. Date of Enter into Meningococcal Conjugate Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Meningococcal Conjugate Market Size by Type (2015-2020) (Million US$)
Table 30. Global Meningococcal Conjugate Market Size Share by Type (2015-2020)
Table 31. Global Meningococcal Conjugate Revenue Market Share by Type (2021-2026)
Table 32. Global Meningococcal Conjugate Market Size Share by Application (2015-2020)
Table 33. Global Meningococcal Conjugate Market Size by Application (2015-2020) (Million US$)
Table 34. Global Meningococcal Conjugate Market Size Share by Application (2021-2026)
Table 35. North America Key Players Meningococcal Conjugate Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Meningococcal Conjugate Market Share (2019-2020)
Table 37. North America Meningococcal Conjugate Market Size by Type (2015-2020) (Million US$)
Table 38. North America Meningococcal Conjugate Market Share by Type (2015-2020)
Table 39. North America Meningococcal Conjugate Market Size by Application (2015-2020) (Million US$)
Table 40. North America Meningococcal Conjugate Market Share by Application (2015-2020)
Table 41. Europe Key Players Meningococcal Conjugate Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Meningococcal Conjugate Market Share (2019-2020)
Table 43. Europe Meningococcal Conjugate Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Meningococcal Conjugate Market Share by Type (2015-2020)
Table 45. Europe Meningococcal Conjugate Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Meningococcal Conjugate Market Share by Application (2015-2020)
Table 47. China Key Players Meningococcal Conjugate Revenue (2019-2020) (Million US$)
Table 48. China Key Players Meningococcal Conjugate Market Share (2019-2020)
Table 49. China Meningococcal Conjugate Market Size by Type (2015-2020) (Million US$)
Table 50. China Meningococcal Conjugate Market Share by Type (2015-2020)
Table 51. China Meningococcal Conjugate Market Size by Application (2015-2020) (Million US$)
Table 52. China Meningococcal Conjugate Market Share by Application (2015-2020)
Table 53. Japan Key Players Meningococcal Conjugate Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Meningococcal Conjugate Market Share (2019-2020)
Table 55. Japan Meningococcal Conjugate Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Meningococcal Conjugate Market Share by Type (2015-2020)
Table 57. Japan Meningococcal Conjugate Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Meningococcal Conjugate Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Meningococcal Conjugate Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Meningococcal Conjugate Market Share (2019-2020)
Table 61. Southeast Asia Meningococcal Conjugate Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Meningococcal Conjugate Market Share by Type (2015-2020)
Table 63. Southeast Asia Meningococcal Conjugate Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Meningococcal Conjugate Market Share by Application (2015-2020)
Table 65. India Key Players Meningococcal Conjugate Revenue (2019-2020) (Million US$)
Table 66. India Key Players Meningococcal Conjugate Market Share (2019-2020)
Table 67. India Meningococcal Conjugate Market Size by Type (2015-2020) (Million US$)
Table 68. India Meningococcal Conjugate Market Share by Type (2015-2020)
Table 69. India Meningococcal Conjugate Market Size by Application (2015-2020) (Million US$)
Table 70. India Meningococcal Conjugate Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Meningococcal Conjugate Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Meningococcal Conjugate Market Share (2019-2020)
Table 73. Central & South America Meningococcal Conjugate Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Meningococcal Conjugate Market Share by Type (2015-2020)
Table 75. Central & South America Meningococcal Conjugate Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Meningococcal Conjugate Market Share by Application (2015-2020)
Table 77. Sanofi Pasteur Company Details
Table 78. Sanofi Pasteur Business Overview
Table 79. Sanofi Pasteur Product
Table 80. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2015-2020) (Million US$)
Table 81. Sanofi Pasteur Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Product
Table 85. Pfizer Revenue in Meningococcal Conjugate Business (2015-2020) (Million US$)
Table 86. Pfizer Recent Development
Table 87. Glaxo Smith Kline Company Details
Table 88. Glaxo Smith Kline Business Overview
Table 89. Glaxo Smith Kline Product
Table 90. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2015-2020) (Million US$)
Table 91. Glaxo Smith Kline Recent Development
Table 92. Hualan Biological Engineering Company Details
Table 93. Hualan Biological Engineering Business Overview
Table 94. Hualan Biological Engineering Product
Table 95. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2015-2020) (Million US$)
Table 96. Hualan Biological Engineering Recent Development
Table 97. JN International Medical Corporation Company Details
Table 98. JN International Medical Corporation Business Overview
Table 99. JN International Medical Corporation Product
Table 100. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2015-2020) (Million US$)
Table 101. JN International Medical Corporation Recent Development
Table 102. Baxter International Company Details
Table 103. Baxter International Business Overview
Table 104. Baxter International Product
Table 105. Baxter International Revenue in Meningococcal Conjugate Business (2015-2020) (Million US$)
Table 106. Baxter International Recent Development
Table 107. Merck Company Details
Table 108. Merck Business Overview
Table 109. Merck Product
Table 110. Merck Revenue in Meningococcal Conjugate Business (2015-2020) (Million US$)
Table 111. Merck Recent Development
Table 112. Serum Institute of India Business Overview
Table 113. Serum Institute of India Product
Table 114. Serum Institute of India Company Details
Table 115. Serum Institute of India Revenue in Meningococcal Conjugate Business (2015-2020) (Million US$)
Table 116. Serum Institute of India Recent Development
Table 117. Biomed Company Details
Table 118. Biomed Business Overview
Table 119. Biomed Product
Table 120. Biomed Revenue in Meningococcal Conjugate Business (2015-2020) (Million US$)
Table 121. Biomed Recent Development
Table 122. Novartis Company Details
Table 123. Novartis Business Overview
Table 124. Novartis Product
Table 125. Novartis Revenue in Meningococcal Conjugate Business (2015-2020) (Million US$)
Table 126. Novartis Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Conjugate Market Share by Type: 2020 VS 2026
Figure 2. Menactra Features
Figure 3. Menveo Features
Figure 4. NeisVac-C Features
Figure 5. Nimenrix Features
Figure 6. Others Features
Figure 7. Global Meningococcal Conjugate Market Share by Application: 2020 VS 2026
Figure 8. Children Case Studies
Figure 9. Preteens or Teens Case Studies
Figure 10. Adults Case Studies
Figure 11. Meningococcal Conjugate Report Years Considered
Figure 12. Global Meningococcal Conjugate Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Meningococcal Conjugate Market Share by Regions: 2020 VS 2026
Figure 14. Global Meningococcal Conjugate Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Meningococcal Conjugate Market Share by Players in 2019
Figure 17. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Conjugate as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2019
Figure 19. North America Meningococcal Conjugate Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Meningococcal Conjugate Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Meningococcal Conjugate Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Meningococcal Conjugate Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Meningococcal Conjugate Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Meningococcal Conjugate Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Meningococcal Conjugate Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
髄膜炎菌ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Meningococcal Vaccines Market The global Meningococcal Vaccines market size is projected to reach US$ 250.5 million by 2026, from US$ 239 million in 2020, at a CAGR of 4.4%% during 2021-2026. Global Meningococcal Vaccines Scope and Market Size Meningococcal Vacci…- 抗体薬物複合体の世界市場（～2026年） Market Analysis and Insights: Global Antibody Drug Conjugate Market The global Antibody Drug Conjugate market size is projected to reach US$ 1831.1 million by 2026, from US$ 1696.9 million in 2020, at a CAGR of 7.3%% during 2021-2026. Global Antibody Drug Conjugate Scope and Market Size Antibody Dru…
- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…
- 獣医用ワクチンの世界市場（～2026年） Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock product…
- 子供用歯磨き粉の世界市場（～2026年） Market Analysis and Insights: Global Children Toothpaste Market The global Children Toothpaste market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Children Toothpaste Scope and Market Size Children Toothpaste market is seg…